UBS initiated coverage of CG Oncology (CGON) with a Buy rating and $60 price target The firm launched coverage of SMID cap biotech sector with ...

UBS initiated coverage of Cullinan Therapeutics (CGEM) with a Buy rating and $30 price target The firm launched coverage of SMID cap biotech ...

Syndax Pharmaceuticals (SNDX) stock gains as company becomes top pick in UBS's newly lauched coverage of SMID cap biotechs.

With Android 15 QPR1 Beta 3, Google has tweaked the color design of Themed icons in both the light and dark modes. With the system dark mode enabled, Themed icons are appreciably lighter than before, ...

As people get ready to vote, here's what's been going on with job growth, federal debt, and other economic measures.

What factors have driven these changes? Is the pandemic still making an impact? The Art Market 2024, published by Art Basel and UBS provides a comprehensive macro-economic analysis of the state of the ...

Apps for creativity, productivity or fun. Award-winning blockbusters to indie productions. Series of your favourite sitcoms and episodes of the latest programmes. It’s all here and easier to find.